Perforated Duodenal Ulcer as a Cause of Death in Patients on Prolonged High-Dose Corticosteroid Therapy
Introduction to Perforated Duodenal Ulcer Risk
- The British Society of Gastroenterology recommends that prolonged steroid use (>3 months continuous therapy) carries increased infection risk, osteoporosis, and cardiovascular disease—all contributing to mortality 1
- Prolonged high-dose corticosteroid use significantly increases the risk of gastrointestinal bleeding and perforation, with the patient's dose and duration far exceeding standard protocols 2, 1
Clinical Presentation and Diagnosis
- Sudden death in a bathtub suggests rapid cardiovascular collapse from peritonitis and septic shock, which is the typical presentation of perforated peptic ulcer 2
- Perforated ulcers can present with minimal warning in patients on corticosteroids because steroids mask inflammatory symptoms and blunt the febrile response 2
Infection Risk and Corticosteroid Therapy
- Infection is a major cause of mortality in patients on corticosteroids, with the 2017 AGA guidelines emphasizing that infections account for 24% of all deaths in severe conditions requiring corticosteroids 3
- Prolonged prednisolone use (>3 months) is associated with increased mortality, with infection being a primary driver 1
Critical Clinical Pitfalls and Management
- The patient continued 60 mg daily for 12 weeks without tapering—this violates fundamental corticosteroid management principles, and methylprednisolone should be weaned slowly (6-14 days) 2
- Patients on prolonged high-dose corticosteroids require proton pump inhibitor prophylaxis to prevent ulcer formation and perforation 1
- Regular monitoring for infection, cardiovascular risk factors, and gastrointestinal symptoms is necessary, as early deaths are related to infections or disease activity, while cardiovascular complications account for late mortalities 4, 5
Corticosteroid-Related Complications
Introduction to Corticosteroid Risks
- The British Association of Dermatologists guidelines document that mortality during the first year is significantly higher in patients treated with high doses of systemic corticosteroids (prednisolone equivalent >40 mg daily) 6, 7, 8
Management of Corticosteroid Therapy
- The British Association of Dermatologists recommends gradual reduction of corticosteroids over 8 weeks, initially by one-third to one-quarter down to 15 mg daily, then by 2.5 mg decrements 6, 7
- Patients on prolonged high-dose corticosteroids require proton pump inhibitor prophylaxis to prevent ulcer formation and perforation, and methylprednisolone should be weaned slowly (6-14 days) and not stopped rapidly or abruptly 9, 10
- Regular monitoring for gastrointestinal symptoms is necessary, as infection surveillance is particularly important since corticosteroids blunt the febrile response 10
Perforated Duodenal Ulcer Due to Corticosteroid Therapy
Clinical Presentation and Risk Factors
- The concomitant use of corticosteroids increases the risk of gastrointestinal side effects, and the FDA label specifically warns about this complication, with patients on prolonged high-dose corticosteroids being at higher risk of peptic ulcer disease and perforation 11, 12